Nasopharyngeal cancer, a rare form of head and neck cancer, arises in the nasopharynx, the upper part of the throat behind the nose. Research in this field focuses on understanding the disease's molecular mechanisms, risk factors, and improving treatment outcomes. Key areas of investigation include exploring the role of Epstein-Barr virus (EBV) infection, genetic predisposition, and environmental factors such as diet and tobacco use in cancer development. Innovative therapies such as immunotherapy and targeted molecular treatments are being studied to enhance treatment efficacy and reduce side effects. Early detection methods, including advanced imaging techniques and biomarker identification, are also under scrutiny to improve prognosis and survival rates. Collaborative efforts between clinicians, researchers, and pharmaceutical companies drive progress in combating this challenging cancer type.






Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States